Skip to main content
My Schedule
Daily Schedule
Full Schedule
Browse by Date
Saturday, September 28, 2024
Sunday, September 29, 2024
Monday, September 30, 2024
Tuesday, October 1, 2024
Wednesday, October 2, 2024
Browse by Title
Browse by Presenter
Browse by Track
Browse by Session Type
Browse by Focus Area
Evaluate/Claim Credit
Posters & Abstracts
Posters
Abstracts
Exhibitors
Featured Exhibitors
Browse by Company
Browse by Booths
Browse by Category
Floor Plan
Exhibitor Events
Product Showcase
Browse by Product
Browse by Company
Meeting Info
Convention Center Maps
Event Support
Event Code of Conduct
Toggle navigation
Login
Search
Home
My Schedule
+
Daily Schedule
Full Schedule
+
Browse by Date
Saturday, September 28, 2024
Sunday, September 29, 2024
Monday, September 30, 2024
Tuesday, October 1, 2024
Wednesday, October 2, 2024
Browse by Title
Browse by Presenter
Browse by Track
Browse by Session Type
Browse by Focus Area
Evaluate/Claim Credit
+
Posters & Abstracts
Posters
Abstracts
+
Exhibitors
Featured Exhibitors
Browse by Company
Browse by Booths
Browse by Category
Floor Plan
Exhibitor Events
+
Product Showcase
Browse by Product
Browse by Company
Meeting Info
Convention Center Maps
Event Support
Event Code of Conduct
Icon Legend
Presentation Icons
Event Add-on
In Person Only
Off-site Event
Location: Marriott Marquis
Main Session
Favorite
Facebook
Tweet
EDU 23 - Multimodality Treatment De-Intensification in Low-Risk Breast Cancer: What are the Limits?
Radiotherapy De-Escalation and Options for Radiation Monotherapy
Monday, September 30, 2024
11:27 AM – 11:47 AM
ET
Location: Room 147
Speaker(s)
Naamit Gerber, MD
NYU Langone Medical Center
Bronx, New York, United States
Learning Objectives:
Identify patients who may safely avoid sentinel lymph node biopsy.
Understand the range of endocrine therapy approaches that can be considered for patients with low-risk breast cancer.
Know the data in support of, as well as the existing studies that evaluate the option of radiation without endocrine therapy for selected patients.
Back to Top